110 related articles for article (PubMed ID: 32180557)
1. Regulation of hepatic glutamine metabolism by miR-122.
Sengupta D; Cassel T; Teng KY; Aljuhani M; Chowdhary VK; Hu P; Zhang X; Fan TW; Ghoshal K
Mol Metab; 2020 Apr; 34():174-186. PubMed ID: 32180557
[TBL] [Abstract][Full Text] [Related]
2. Loss of vascular endothelial glutaminase inhibits tumor growth and metastasis, and increases sensitivity to chemotherapy.
Ngwa VM; Edwards DN; Hwang Y; Karno B; Wang X; Yan C; Richmond A; Brantley-Sieders DM; Chen J
Cancer Res Commun; 2022 Jul; 2(7):694-705. PubMed ID: 36381236
[TBL] [Abstract][Full Text] [Related]
3. Glutaminase deficiency in rod photoreceptors disrupts nonessential amino acid levels to activate the integrated stress response and induce rapid degeneration.
Goswami MT; Weh E; Subramanya S; Weh KM; Durumutla HB; Hager H; Miller N; Chaudhury S; Andren A; Sajjakulnukit P; Besirli CG; Lyssiotis CA; Wubben TJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38586045
[TBL] [Abstract][Full Text] [Related]
4. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.
Zhang M; Zhou X; Wang B; Yung BC; Lee LJ; Ghoshal K; Lee RJ
J Control Release; 2013 Jun; 168(3):251-61. PubMed ID: 23567045
[TBL] [Abstract][Full Text] [Related]
5. ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
Guillén-Pérez YM; Ortiz-Ruiz MJ; Márquez J; Pandiella A; Esparís-Ogando A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542254
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stress.
Shi J; Pabon K; Ding R; Scotto KW
J Biol Chem; 2024 Apr; 300(6):107299. PubMed ID: 38641063
[TBL] [Abstract][Full Text] [Related]
7. Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism.
Michalak KP; Maćkowska-Kędziora A; Sobolewski B; Woźniak P
Oxid Med Cell Longev; 2015; 2015():964321. PubMed ID: 26583064
[TBL] [Abstract][Full Text] [Related]
8. Stable Isotope Resolved Metabolomics Analysis of Ribonucleotide and RNA Metabolism in Human Lung Cancer Cells.
Fan TW; Tan J; McKinney MM; Lane AN
Metabolomics; 2012 Jun; 8(3):517-527. PubMed ID: 26146495
[TBL] [Abstract][Full Text] [Related]
9. Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma.
Ziki RA; Colnot S
JHEP Rep; 2024 May; 6(5):101077. PubMed ID: 38699532
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Raf1 Regulates Glutamine Catabolism.
Shanderson RL; Ferguson ID; Siprashvili Z; Ducoli L; Li AM; Miao W; Srinivasan S; Velasco MG; Li Y; Ye J; Khavari PA
bioRxiv; 2024 Mar; ():. PubMed ID: 38496616
[TBL] [Abstract][Full Text] [Related]
11. Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice.
Teng KY; Barajas JM; Hu P; Jacob ST; Ghoshal K
Biology (Basel); 2020 Jul; 9(7):. PubMed ID: 32650615
[TBL] [Abstract][Full Text] [Related]
12. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
Jin H; Wang S; Zaal EA; Wang C; Wu H; Bosma A; Jochems F; Isima N; Jin G; Lieftink C; Beijersbergen R; Berkers CR; Qin W; Bernards R
Elife; 2020 Oct; 9():. PubMed ID: 33016874
[TBL] [Abstract][Full Text] [Related]
13. Broadening horizons: the role of ferroptosis in cancer.
Chen X; Kang R; Kroemer G; Tang D
Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
[TBL] [Abstract][Full Text] [Related]
14. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
Suzuki S; Venkatesh D; Kanda H; Nakayama A; Hosokawa H; Lee E; Miki T; Stockwell BR; Yokote K; Tanaka T; Prives C
Cancer Res; 2022 Sep; 82(18):3209-3222. PubMed ID: 35895807
[TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
[TBL] [Abstract][Full Text] [Related]
16. Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.
Nguyen TT; Katt WP; Cerione RA
Future Drug Discov; 2023 Mar; 4(4):FDD79. PubMed ID: 37009252
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
[TBL] [Abstract][Full Text] [Related]
18. Two Faces of Glutaminase GLS2 in Carcinogenesis.
Buczkowska J; Szeliga M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067269
[TBL] [Abstract][Full Text] [Related]
19. The interplay of miRNAs and ferroptosis in diseases related to iron overload.
Jin S; Liu PS; Zheng D; Xie X
Apoptosis; 2024 Feb; 29(1-2):45-65. PubMed ID: 37758940
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
